BrainCheck, Inc. is a digital cognitive assessment and care planning company headquartered in Austin, Texas, that offers a mobile interactive test and related healthcare services.
Subscribe to see BrainCheck’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
BrainCheck is a healthtech company headquartered in United States. Its most recent funding round, Series A, raised $13M in February 2026. Xcout tracks 12 named people at BrainCheck, including Chris Loughlin (Chief Executive Officer).
6 more named people on record for BrainCheck, with roles, board committees and tenure — see the full roster →
The 5 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $13M | 3 named | |
| Series A | $15M | 3 named | |
| SEC Form D filing | $8.9M | — | |
| SEC Form D filing | $4.7M | — | |
| Series A | $8M | 3 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of BrainCheck's closest competitors — see the full list of competitors and alternatives →
Neurotrack Technologies, Inc. is a small business utilizing NIA funding to develop digital cognitive screening tools to help providers assess for mild cognitive impairment and dementia.
Altoida is a commercial-stage digital health company headquartered in Washington, D.C., that uses advanced neuroscience, machine learning, and augmented reality to evaluate neurological health.
Everly Health is a digital healthcare parent company headquartered in Austin, Texas. It oversees subsidiary brands such as Everlywell, Everly Health Solutions, Natalist, and Everly Diagnostics to provide at-home diagnostics, telehealth, and clinical testing solutions.
Virtuleap is a leader in cognitive therapeutics and diagnostics that combines neuroscience, virtual reality, and artificial intelligence, with its headquarters located in Lisbon, Portugal.
i2Dx, Inc. is a US-based company founded in 2012 that develops a multimodal, cloud-based diagnostic platform. The platform is designed for the assessment and diagnosis of neurological disorders using quantitative digital assessments.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.